Zantac and Ranitidine

Zantac (Ranitidine) Dangers

 

Zantac was introduced in 1983 as the first of a new class of medications: histamine H2-receptor antagonists (H2 blockers).

​

Zantac has been profitably marketed as a safe treatment for heartburn, acid indigestion, sour stomach, gastroesophageal reflux disease (GERD) and other conditions. 

​

The active ingredient in Zantac is ranitidine.  Ranitidine’s molecular structure breaks down to produce dangerous levels of the chemical N-Nitrosodimethylamine (NDMA) when exposed to high temperatures inside the human body or during transport (such as in a hot car).

​

For decades, NDMA has been known to increase the risk of cancer in humans. While the drug makers, suppliers and marketers knew or should have known about the link between Zantac, NDMA and cancer, they failed to adequately research the risk or warn users and the medical community.

​

Following exposure for only a few months, experts indicate that NDMA may result in the development of cancer from Zantac.

 

Cancers Included in Zantac Lawsuit

​

Have you or your loved one been diagnosed with any of the following cancers?

​

• Bladder

• Breast

• Esophageal

• Intestinal

• Kidney/Renal

• Liver

• Lung

• Pancreatic

• Prostate

• Stomach

• Testicular

• Throat/Nasal

• Thyroid

• Uterine 

​

Filing a Zantac Lawsuit

​

A Zantac cancer lawsuit may help victims or their surviving relatives recover damages for:

• Medical costs

• Lost wages

• Pain and suffering 

• Disability or permanent injury

• Punitive damages

• Wrongful death

 

You may be eligible for compensation.  There is no charge for a case review.